News Daily News Media Scrutiny Over Risks and Benefits of Statins Impacts Patient Use Michael O'Riordan June 28, 2016
News Daily News ‘Lower Is Better’ Mantra for LDL Cholesterol Questioned by New Analysis, but Experts Urge Caution Todd Neale June 22, 2016
News Daily News Pharmacists Can Take an Active Role in Lowering CV Risk Factors, Likelihood of Events Michael H. Wilson June 21, 2016
News Daily News Detection and Treatment of Severe FH Depends on LDL Levels, Not Genes, Says Expert Panel Michael O'Riordan June 09, 2016
News Conference News EAS 2016 Non-HDL Cholesterol, Inflammation Appear to Be Linked in Patients Undergoing Elective PCI Yael L. Maxwell June 08, 2016
News Conference News EAS 2016 Preservation of LDL Cholesterol Targets for Lipid Lowering in New European Guidance Gets Blessing of Prevention Experts Yael L. Maxwell June 06, 2016
News Daily News Interactive Smartphone App Can Motivate MI Patients to Take Their Meds Caitlin E. Cox June 06, 2016
News Daily News Gut Bacteria-Produced Compound May Help Identify Atherosclerotic Burden in Patients With CAD Todd Neale June 01, 2016
News Daily News Statins Tied to Lower Mortality, Amputation Risks in PAD Michael O'Riordan May 09, 2016
News Daily News STICS: No Benefit to Perioperative Statin Therapy in Cardiac Surgery, but Acute Kidney Injury Risk Increased Michael O'Riordan May 05, 2016
News Features Requiem for a Heavyweight: Big Brand Statin Era Comes to a Close as Crestor Heads Off-Patent Michael O'Riordan May 03, 2016
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for April 2016 Shelley Wood April 29, 2016
News Daily News No More Niacin, Fibrate Combinations With Statins: FDA Michael O'Riordan April 19, 2016
News Daily News Statin Therapy Alters Composition of Coronary Plaques, Virtual Histology-IVUS Study Shows Michael O'Riordan April 14, 2016
News Conference News ACC 2016 STEPATHLON: A Mobile-Based Exercise Program Increased Physical Activity and Promoted Weight Loss Michael O'Riordan April 04, 2016
News Conference News ACC 2016 Statin Intolerance and FH: GAUSS-3 Finds Benefit With Evolocumab, While Another Study Exposes Lifetime Risks of FH Michael O'Riordan April 03, 2016
News Conference News ACC 2016 HOPE-3: Reducing LDL Cholesterol Improves Outcomes in Intermediate-Risk Patients, but BP-Lowering Does Not Michael O'Riordan April 02, 2016
News Daily News ACC Updates LDL-Cholesterol Lowering Recommendations, Making Room for Ezetimibe and PCSK9 Inhibitors Michael O'Riordan April 02, 2016
News Daily News ACC actualiza las recomendaciones para bajar el colesterol LBD, abriendo un espacio para el uso de Ezetimibe y de los inhibidores de PCSK9 Michael O'Riordan April 02, 2016